Literature DB >> 12456333

Renal fibrosis.

H William Schnaper1, Jeffrey B Kopp.   

Abstract

Renal fibrosis causes significant morbidity and mortality as the primary acquired lesion leading to the need for dialysis or kidney transplantation. Fibrosis can occur in either the filtering or reabsorptive component of the nephron, the functional unit of the kidney. Experimental models have identified a number of factors that contribute to renal scarring, particularly derangements of physiology involved in the autoregulation of glomerular filtration. This in turn leads to replacement of normal structures with accumulated extracellular matrix (ECM). A spectrum of changes in the physiology of individual cells leads to the production of numerous peptide and non-peptide fibrogens that stimulate alterations in the balance between ECM synthesis and degradation to favor scarring. Other proteins and small molecules may have anti-fibrotic effects. Manipulation of these opposing systems holds the promise of effective treatments for chronic progressive kidney disease.

Entities:  

Mesh:

Year:  2003        PMID: 12456333     DOI: 10.2741/925

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  11 in total

Review 1.  Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders.

Authors:  Sonsoles Piera-Velazquez; Zhaodong Li; Sergio A Jimenez
Journal:  Am J Pathol       Date:  2011-07-19       Impact factor: 4.307

Review 2.  Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Jill Norman
Journal:  Biochim Biophys Acta       Date:  2011-07-01

3.  Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.

Authors:  Asada Leelahavanichkul; Qin Yan; Xuzhen Hu; Christoph Eisner; Yuning Huang; Richard Chen; Diane Mizel; Hua Zhou; Elizabeth C Wright; Jeffrey B Kopp; Jürgen Schnermann; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2010-08-25       Impact factor: 10.612

4.  Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization.

Authors:  Tatsuya Suwabe; Yoshifumi Ubara; Koki Mise; Toshiharu Ueno; Keiichi Sumida; Masayuki Yamanouchi; Noriko Hayami; Junichi Hoshino; Masahiro Kawada; Aya Imafuku; Rikako Hiramatsu; Eiko Hasegawa; Naoki Sawa; Kenmei Takaichi
Journal:  J Am Soc Nephrol       Date:  2015-11-30       Impact factor: 10.121

Review 5.  The story of Notch and chronic kidney disease.

Authors:  Shuchita Sharma; Yasemin Sirin; Katalin Susztak
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-01       Impact factor: 2.894

Review 6.  MicroRNAs and the regulation of fibrosis.

Authors:  Xiaoying Jiang; Eleni Tsitsiou; Sarah E Herrick; Mark A Lindsay
Journal:  FEBS J       Date:  2010-05       Impact factor: 5.542

Review 7.  Vesicoureteral reflux and the extracellular matrix connection.

Authors:  Fatima Tokhmafshan; Patrick D Brophy; Rasheed A Gbadegesin; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2016-05-02       Impact factor: 3.714

8.  Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia.

Authors:  W H Yiu; C-J Pan; R A Ruef; W-T Peng; M F Starost; B C Mansfield; J Y Chou
Journal:  Kidney Int       Date:  2007-12-12       Impact factor: 10.612

Review 9.  Invasive Intraneural Interfaces: Foreign Body Reaction Issues.

Authors:  Fiorenza Lotti; Federico Ranieri; Gianluca Vadalà; Loredana Zollo; Giovanni Di Pino
Journal:  Front Neurosci       Date:  2017-09-06       Impact factor: 4.677

10.  A microRNA-30e/mitochondrial uncoupling protein 2 axis mediates TGF-β1-induced tubular epithelial cell extracellular matrix production and kidney fibrosis.

Authors:  Lei Jiang; Wenjing Qiu; Yang Zhou; Ping Wen; Li Fang; Hongdi Cao; Ke Zen; Weichun He; Chenyu Zhang; Chunsun Dai; Junwei Yang
Journal:  Kidney Int       Date:  2013-03-20       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.